LBRX Stock Analysis: Buy, Sell, or Hold?
LBRX - LB Pharmaceuticals Inc Common Stock
$48.00
-0.18 (-0.37%)
▼
5d:
+19.76%
30d:
+42.26%
90d:
+50.09%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 11, 2026
3d
Get Alerted When LBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: LBRX is 16.6% above its trading range ($41.17). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: LBRX is 16.6% above its trading range ($41.17). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: LBRX is currently trading at $48.00, which is considered extended relative to its 30-day fair value range of $30.89 to $41.17.
Technical Outlook: Technically, LBRX is in a uptrend. The price is approaching resistance at $49.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.88 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LBRX is in a uptrend. The price is approaching resistance at $49.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.88 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$30.89 -
$41.17
Company Quality Score
53/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
54.2%
All Signals
- BEARISH: Price significantly overextended (+16.6% above its trading range)
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($45.88)
- WARNING: Recommendation downgraded due to 16.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$30.89 -
$41.17
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$4.24
(8.8%)
Support & Resistance Levels
Support Level
$34.03
Resistance Level
$49.14
Current Trend
Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.63
Wall Street Target
$45.88
(+12.2%)
Share & Embed Analysis
Last updated: August 07, 2026 4:07 PM ET
Data refreshes hourly during market hours. Next update: 5:07 PM
Data refreshes hourly during market hours. Next update: 5:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 51 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |